Mitochondria and Chronic Kidney Disease

Summary

Mitochondria and Chronic Kidney Disease is a clinical trial^[1].

Key Facts

• Mitochondria and Chronic Kidney Disease is in the country of United States^[2].
• Mitochondria and Chronic Kidney Disease's instance of is recorded as clinical trial^[3].
• Mitochondria and Chronic Kidney Disease's start time is recorded as +2017-08-01T00:00:00Z^[4].
• Mitochondria and Chronic Kidney Disease's end time is recorded as +2018-06-30T00:00:00Z^[5].
• Mitochondria and Chronic Kidney Disease's sponsor is recorded as Vanderbilt University Medical Center^[6].
• Mitochondria and Chronic Kidney Disease's number of participants is recorded as {'unit': '1', 'amount': '+11'}^[7].
• Mitochondria and Chronic Kidney Disease's title is recorded as Mitochondrial Dysfunction in Chronic Kidney Disease^[8].
• Mitochondria and Chronic Kidney Disease's short name is recorded as MitoCKD^[9].
• Mitochondria and Chronic Kidney Disease's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[10].
• Mitochondria and Chronic Kidney Disease's ClinicalTrials.gov ID is recorded as NCT03177798^[11].
• Mitochondria and Chronic Kidney Disease's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+78'}^[12].
• Mitochondria and Chronic Kidney Disease's research intervention is recorded as bradykinin triacetate^[13].
• Mitochondria and Chronic Kidney Disease's clinical trial phase is recorded as phase II clinical trial^[14].
• Mitochondria and Chronic Kidney Disease's research site is recorded as Vanderbilt University Medical Center^[15].
• Mitochondria and Chronic Kidney Disease's principal investigator is recorded as Jorge L. Gamboa^[16].
• Mitochondria and Chronic Kidney Disease's study type is recorded as interventional study^[17].